Not finding it? Sign in to also search OpenAlex live.
-
The potential benefit of statin prescription based on prediction of treatment responsiveness in older individuals: an application to the PROSPER randomized controlled trial2023 European Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Tri‐Long Nguyen, Stella Trompet, John Brodersen, Jeroen Hoogland, Thomas P. A. Debray, Naveed A. Sattar, +2 more
4citations -
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment2026 Nature Biotechnology article Biochemistry, Genetics and Molecular Biology Genetics, Aging, and Longevity in Model Organisms Open access
Alex A. Zhavoronkov, Fedor Galkin, Shan Chen, Feng Ren, Alex Aliper, Mikhail O. Durymanov, +13 more
4citations -
Dopaminergic treatment strategies for people with Parkinson’s disease in Europe: a retrospective analysis of PRISM trial data2023 Neurological Sciences article Medicine Parkinson's Disease Mechanisms and Treatments Open access
L T Hansen, Victoria Sofie Witzig, Jörg Bernhard Schulz, Florian Holtbernd
2citations -
UV1 cancer vaccine in pembrolizumab-treated patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma: results from the randomized phase 2 FOCUS trial
Anna Paula Brandt, Konrad Friedrich Klinghammer, Christoph Schultheiß, Lisa Paschold, Claudia Wickenhauser, Marcus Bauer, +17 more
1citations -
Nationwide implementation of best practices in pancreatic cancer care (PACAP-1): Stepped-wedge cluster randomized trial.2023 Journal of Clinical Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access
Tara M. Mackay, Anouk E.J. Latenstein, Simone Augustinus, Lydia G. van der Geest, Auke Bogte, Bert A. Bonsing, +14 more
0citations -
Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
John M.S. Bartlett, Keying Xu, Jenna Wong, Gregory R. Pond, Yi Zhang, Melanie Spears, +12 more
0citations -
Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial2020 European Heart Journal article Medicine Lipoproteins and Cardiovascular Health Open access cited by 2 patents
Michael J. Szarek, Vera Bittner, Philip E. Aylward, Marie T. Baccara‐Dinet, Deepak L. Bhatt, Rafael Díaz, +16 more
221citations -
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)2021 Journal of Hepatology article Medicine Liver Disease and Transplantation Open access cited by 1 patent
Cornelius Engelmann, Adam Herber, Annegret Franke, Tony Bruns, Philipp Alexander Reuken, Ingolf Schiefke, +22 more
146citations -
Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial.2020 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Surgical Treatments
Geke A.P. Hospers, Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, Corrie A.M. Marijnen, Hein Putter, +14 more
111citations -
Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study2024 American Journal of Kidney Diseases article Medicine Diabetes Treatment and Management Open access
Emilie J. Lambourg, Edouard L. Fu, Stuart J. McGurnaghan, Bryan Ronald Conway, Neeraj Dhaun, Christopher Henry Grant, +13 more
7citations -
Factors associated with formal and informal resource utilization in nursing home patients with and without dementia: cross-sectional analyses from the COSMOS trial2022 BMC Health Services Research article Health Professions Geriatric Care and Nursing Homes Open access
Maarja Vislapuu, Line Iden Berge, Renira C. Angeles, Egil Kjerstad, Janne Mannseth, Wilco P. Achterberg, +1 more
3citations -
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial2026 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Christine Desmedt, Ha-Linh Nguyen, Sabine C. Linn, Otto Metzger, Coralie Poncet, Jelle Wesseling, +13 more
0citations -
Second-Line Bosutinib Is Effective and Feasible in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) - an Analysis of a Subcohort of the Bodo Trial (CML-VII-study of the German CML Study Group)
Susanne Isfort, Kirsi Marjaana Manz, Lino Lars Teichmann, Martina Margrit Crysandt, Andreas Burchert, Andreas Hochhaus, +18 more
0citations -
A comparison of conservative versus surgical treatment in patients with foot drop due to peroneal nerve entrapment: results of a prematurely terminated randomized controlled trial
Christophe Oosterbos, Annie S. Dubuisson, Frank J. M. Weyns, Justus L Groen, Sophie Schuind, Rik Demaerel, +11 more
0citations -
Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial2020 European Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Rafael Díaz, Qian H Li, Deepak L. Bhatt, Vera Bittner, Marie T. Baccara‐Dinet, Shaun G. Goodman, +13 more
58citations -
Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial2023 Journal of the American Heart Association article Medicine Lipoproteins and Cardiovascular Health Open access
Shaun G. Goodman, Philippe Gabríel Steg, Yann Poulouin, Deepak L. Bhatt, Vera Bittner, Rafael Díaz, +8 more
43citations -
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, Hein Putter, Irıs D. Nagtegaal, +9 more
43citations